Cardiovascular disease is the leading cause of death around the world. According to a study from the World Economic Forum, the economic burden of this disease to society reached US\$ 863 billion in 2010, with an estimation to rise by 22% to US\$ 1,044 in 2030^\[[@r1]\]^. Likewise, recent studies have shown that in Brazil ischemic heart disease and stroke have been the main cause of death since the end of the 1960s, costing a total of R\$ 56.2 billion just in 2015^\[[@r2],[@r3]\]^. Due to Brazil's large size, its 27 states have developed unevenly, so states located in the south and southeast regions of the country are more developed and have the best infrastructure^\[[@r2]\]^. Hence, such differences ought to be considered when allocating resources efficiently to improve healthcare among the population. It is imperative to seek knowledge through locally-based research as its outcomes may be used as a tool to instruct policy makers, regional-level physicians, health professionals and the general population^\[[@r4]\]^.

To establish the Brazilian contribution to cardiovascular disease research, the Scival platform ([www.scival.com](http://www.scival.com)) was used, which analyzes data from several sources such as Scopus and ScienceDirect. In the case of patent article citations, data emanate from European Patent Office, Intellectual Property Office, Japan Patent Office, United States Patent and Trademark Office and the World Intellectual Property Organization. A query was made to retrieve data from Brazil which had been published within the most recent 5-year period (2014-2018) in the field of "Cardiology and Cardiovascular Medicine". One of the key features of Scival is that it disaggregates each field into specific research topics. As approximately 96,000 specific research topics have been defined, topic clusters are formed by aggregating topics with similar research interest, creating a broader area of research^\[[@r5]\]^. It is important to note that a publication can belong to only one topic, consequently, to one topic cluster.

The indicators used for this analysis were the following:

Scholarly output: The number of documents published within the 5-year period in the topic cluster.Growth (%): This indicator represents the increase or decrease of published documents within the specific topic cluster in the 5-year period.International collaboration (%): The proportion of published documents authored by researchers from Brazil and another countries.Field-Weighted Citation Impact (FWCI): Indicator that refers to citations received in the year of publication plus the following 3 years. FWCI of 1.00 means that the publications have been cited at world average for similar publications. Thus, a score of 1.17 indicates that the outputs have been cited 17% more than expected. Contrarily, a FWCI of 0.77 means 23% less cited than the world average.Patent-cited scholarly output: The count of scholarly outputs published by the country that have been cited in patents.

As [Table 1](#t1){ref-type="table"} reveals, the field of "Cardiology and Cardiovascular Medicine" in Brazil is constituted by 47 topic clusters, ordered according to the number of papers published within the 5-year period. The most prolific topic was "Percutaneous coronary intervention; Patients; Myocardial infarction", with 584 papers, of which 49.3% were the product of an international collaboration. While its growth has diminished slightly over the 5-year period, its FWCI score denotes that these papers have been cited 99% more than expected. In fact, the six most prolific topic cluster exhibits an FWCI \>1, revealing the quality of the work published.

###### 

Topic clusters associated to the field of cardiovascular disease.

  Topic cluster                                                                 Scholarly output   Growth (%)   International collaboration (%)   Field-Weighted Citation Impact
  ----------------------------------------------------------------------------- ------------------ ------------ --------------------------------- --------------------------------
  Percutaneous Coronary Intervention; Patients; Myocardial Infarction           584                -1.7         49.3                              2
  Atrial Fibrillation; Patients; Catheter Ablation                              570                54.3         48.8                              1.42
  Cholesterol; Lipids; Atherosclerosis                                          492                15.8         35.8                              2.71
  Sepsis; Acute Kidney Injury; Patients                                         483                0.3          32.7                              2
  Anticoagulants; Patients; Venous Thromboembolism                              472                28.1         31.4                              1.25
  Heart Rate; Blood Pressure; Patients                                          412                27.6         40.3                              0.9
  Wounds and Injuries; Pressure Ulcer; Bandages                                 385                60.6         12.7                              0.56
  Renin-Angiotensin System; Peptidyl-Dipeptidase A; Angiotensins                348                -7.4         36.8                              0.91
  Hypertension; Blood Pressure; Patients                                        337                6.2          35.6                              2.41
  Stroke; Patients; Cerebral Hemorrhage                                         303                4.6          30.7                              1.09
  Heart Failure; Patients; Brain Natriuretic Peptide                            301                -6.5         36.2                              1.76
  Coronary Artery Disease; Patients; Echocardiography                           264                19.3         45.8                              1.07
  Aortic Valve; Mitral Valve; Aortic Valve Stenosis                             253                7.3          37.2                              1.12
  Ischemic Preconditioning; Reperfusion Injury; Ischemic Postconditioning       221                6.5          13.6                              1.01
  Heart Diseases; Patients; Congenital Heart Defects                            211                -30.4        21.8                              0.56
  Abdominal Aortic Aneurysm; Aneurysm; Dissection                               191                -2.6         22.0                              0.47
  Vasodilation; Endothelium; Dilatation                                         171                51.2         16.4                              0.62
  Catheters; Renal Dialysis; Central Venous Catheters                           160                96.3         13.1                              0.47
  Pneumothorax; Lung; Pleural Effusion                                          142                11.6         22.5                              0.59
  Pulmonary Hypertension; Pulmonary Artery; Patients                            136                61.2         47.4                              1.11
  Rehabilitation; Depression; Patients                                          135                63.2         38.5                              0.83
  Heart Arrest; Cardiopulmonary Resuscitation; Out-Of-Hospital Cardiac Arrest   115                23.6         41.2                              1.01
  Peripheral Arterial Disease; Ischemia; Extremities                            113                -28.9        21.2                              1.42
  Vascular Stiffness; Pulse Wave Analysis; Blood Pressure                       109                11.4         33.0                              0.93
  Matrix Metalloproteinases; Matrix Metalloproteinase 9; Metalloproteases       109                -22.8        33.0                              0.7
  Calcium; Calcium Signaling; Ion Channels                                      97                 -6.1         53.6                              0.83
  Uric Acid; Gout; Hyperuricemia                                                95                 20.7         33.7                              1.26
  Lymphedema; Breast Neoplasms; Chylothorax                                     90                 4.2          15.6                              0.51
  Enterovirus; Poliomyelitis; Myocarditis                                       81                 30.5         43.2                              1.5
  Endocarditis; Aneurysm; Patients                                              81                 22.2         18.5                              1.13
  Heart-Assist Devices; Extracorporeal Membrane Oxygenation; Patients           78                 -10.8        20.5                              0.56
  Erythrocyte Indices; Neutrophils; Lymphocytes                                 65                 -25.8        10.8                              0.52
  Hypertrophic Cardiomyopathy; Myosins; Cardiomyopathies                        61                 21.2         32.8                              0.7
  Anthracyclines; Doxorubicin; Neoplasms                                        57                 30.7         28.1                              1.08
  Sarcoidosis; Granuloma; Patients                                              52                 119.4        23.1                              0.6
  Trachea; Thoracic Aorta; Bronchoscopy                                         50                 47.7         16.0                              0.92
  Ischemia; Patients; Superior Mesenteric Artery                                46                 -0.4         17.4                              0.68
  Coronary Vessels; Pulmonary Artery; Fistula                                   39                 -1.5         7.7                               0.14
  Heart Neoplasms; Myxoma; Echocardiography                                     38                 131.2        26.3                              1.27
  Erythrocytes; Contrast Media; Blood                                           37                 -24          21.6                              0.81
  Renal Artery; Renal Artery Obstruction; Hypertension                          36                 25.7         5.6                               0.5
  Hyponatremia; Sodium; Hyperkalemia                                            32                 132.7        34.4                              0.94
  Inferior Vena Cava; Renal Veins; Syndrome                                     32                 177.5        9.4                               0.56
  Heart; Acoustic Waves; Cardiology                                             30                 -13.4        26.7                              0.4
  Pregnancy; Dissection; Coronary Vessels                                       27                 -72.4        14.8                              0.33
  Pericarditis; Pericardial Effusion; Constrictive Pericarditis                 22                 76.1         9.1                               0.32
  Takotsubo Cardiomyopathy; Patients; Electrocardiography                       17                 -7.5         35.3                              0.66

Another important aspect to consider is the impact of the Brazilian papers in patent generation. As Collins and Wyatt^\[[@r6]\]^ stated, the main characteristic of papers cited by patents must be in a rapidly developing field with a high scientific content. To understand the real value of these papers, 509 US patents issued from 1987 to 2003 cited 273 Chilean papers from several disciplines^\[[@r7]\]^. In this regard, [Table 2](#t2){ref-type="table"} summarizes the Brazilian papers cited in 16 patents issued from 2014 to 2018.

###### 

Brazilian papers cited in patents.

  Title                                                                                                                                                                                                                           Year   Source                                              Volume   Pages
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------ --------------------------------------------------- -------- -----------
  Pleural subxyphoid drain confers better pulmonary function and clinical outcomes in chronic obstructive pulmonary disease after off-pump coronary artery bypass grafting: A randomized controlled trial                         2014   Brazilian Journal of Cardiovascular Surgery         29       588-594
  Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation                                                                                                                 2014   Nutrition, Metabolism and Cardiovascular Diseases   24       606-613
  Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: Subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)   2014   Journal of the American College of Cardiology       63       1048-1057
  Statin-associated muscle symptoms: impact on statin therapy - European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management                                                                2015   European Heart Journal                              36       1012-1022
  Management of pulmonary arterial hypertension                                                                                                                                                                                   2015   Journal of the American College of Cardiology       65       1976-1997
  Simplified Method for Vagal Effect Evaluation in Cardiac Ablation and Electrophysiological Procedures                                                                                                                           2015   JACC: Clinical Electrophysiology                    1        451-460
  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary                                                                                         2017   Heart Rhythm                                        14       e445-e494
  Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?                                                                                                                                                      2016   Atherosclerosis                                     248      62-75
  Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients with Peripheral Artery Disease                                                                                                             2016   Journal of the American College of Cardiology       67       2719-2728
  Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension                                                                                           2018   Journal of Clinical Hypertension                    20       935-941

Undoubtedly, research developed by Brazilian investigators in topics related to cardiovascular disease has proven valuable, not only for the academic community, but also for the industry. I believe now is the time to make this research useful for policy makers to influence their assessments.
